Working together with biotechs, the pharmaceutical industry and investors specialized in the biomedical sector (venture capital) is essential when converting knowledge produced at the CNIO into tangible technologies. At the same time, our researchers benefit from the experience and competitive edge they acquire when inter-acting with the business sector.

Among the companies we have partnered with are the following: